NCT00420381
- Conditions
- Adnexal Diseases, Carcinoma, Disease Attributes, +20 more
- Locations
-
- Gynecologic Oncology Group 215-854-0770 Philadelphia, Pennsylvania, United States
Clinical trial condition
Recurrence
Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.
2,312 public trials
521 recruiting studies
Recurrence trial results
NCT01058434
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of South Alabama / Mitchell Cancer Institute Dept. of Mitchell Cancer Inst. Mobile, Alabama, United States
- Central Hematology Oncology Medical Group Alhambra, California, United States
- Central Coast Medical Oncology Corporation Santa Maria, California, United States
- St. Jude Heritage Medical Group Virginia Crosson Cancer Center Yorba Linda, California, United States
NCT02144038
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- University of Texas/MD Anderson Cancer Center Dept.ofMDAndersonCancerCtr(SC) Houston, Texas, United States
- Seattle Cancer Care Alliance Oncology Dept Seattle, Washington, United States
- University of Wisconsin / Paul P. Carbone Comp Cancer Center Dept of Onc. Madison, Wisconsin, United States
- Novartis Investigative Site Prahran, Victoria, Australia
NCT01106508
- Conditions
- Advanced Solid Tumors, Carcinoma, Carcinoma, Basal Cell, +17 more
- Locations
-
- University of California at Los Angeles UCLA LeConte Location Los Angeles, California, United States
- Memorial Sloan Kettering Cancer Center New York, United States
- Novartis Investigative Site Utrecht, Netherlands
- Novartis Investigative Site Zurich, Switzerland
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(3) San Antonio, Texas, United States
- Novartis Investigative Site Melbourne, Australia
- Novartis Investigative Site Frankfurt, Germany
Completed
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
NCT00262990
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Carcinoma, +29 more
- Locations
-
- Alaska Cancer Research & Education Center Anchorage, Alaska, United States
- Northern Arizona Hematology & Oncology Associates Flagstaff, Arizona, United States
- Mayo Center for Women's Health Scottsdale, Arizona, United States
- Northern Arizona Hematology & Oncology Associates Sedona, Arizona, United States
NCT01956695
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Centre Léon Bérard Lyon, Auvergne-Rhône-Alpes, France
- CHU Estaing Clermont-Ferrand, Auvergne, France
- CHU Bretonneau - Centre Henry Kaplan Tours, Centre-Val de Loire, France
- Institut Bergonié Bordeaux, Gironde, France
NCT00612716
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
- Locations
-
- Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States
NCT03114683
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
- Cancer hospital Chinese academy of Medical sciences Beijing, China
NCT00918671
- Conditions
- Brain Diseases, Bronchial Diseases, Bronchiolitis, +28 more
- Locations
-
- Norwegian National headache Centre, NTNU Trondheim, Norway